Biochemistry, Genetics and Molecular Biology
Apolipoprotein B
100%
Triglyceride
91%
Lipoprotein
90%
Secretion (Process)
76%
Blood Plasma
55%
Very Low-Density Lipoprotein
55%
Low-Density Lipoprotein
53%
Apolipoprotein
48%
Lipid
38%
Metabolic Pathway
37%
Insulin Resistance
35%
Triacylglycerol Blood Level
28%
HDL-Cholesterol
26%
Hypertriglyceridemia
19%
Dyslipidemia
19%
Diacylglycerol Lipase
18%
High-Density Lipoprotein
18%
Lipoprotein Metabolism
17%
Diglyceride
17%
Apolipoprotein C3
16%
Apolipoprotein E
15%
Cholesteryl Ester
14%
Triglyceride-Rich Lipoprotein
14%
Statin
13%
Proteasome
13%
Blood Lipids
13%
Microsomal Triglyceride Transfer Protein
13%
Blood Level
13%
Pancreatic Lipase
11%
Triacylglycerol Lipase
11%
Normal Human
11%
Triacylglycerol Level
11%
N-Acetyltransferase
11%
Acyltransferase
11%
Lipogenesis
11%
Oleic Acid
11%
Cholesterol Blood Level
11%
Glucose Level
10%
Steady State
10%
Lipoprotein Blood Level
10%
Transgenic Mouse
10%
Chylomicron
10%
Hyperlipidemia
10%
Iodine-125
10%
Lovastatin
8%
Saturated Fat
8%
Low Density Lipoprotein Cholesterol Level
8%
Macaca fascicularis
8%
Combined Hyperlipidemia
7%
Lipid Level
7%
Pharmacology, Toxicology and Pharmaceutical Science
Lipoprotein
84%
Triacylglycerol
78%
Dyslipidemia
52%
Very Low Density Lipoprotein
45%
Non Insulin Dependent Diabetes Mellitus
43%
Cardiovascular Disease
37%
Low Density Lipoprotein Cholesterol
36%
Low Density Lipoprotein
35%
High Density Lipoprotein Cholesterol
33%
Insulin Resistance
32%
Cardiovascular Risk
30%
Apolipoprotein B
27%
Diabetes Mellitus
25%
Hyperlipidemia
22%
Placebo
21%
Fenofibrate
19%
Statin (Protein)
19%
Disease
18%
Metabolic Syndrome X
17%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
17%
Fibric Acid Derivative
15%
Alirocumab
13%
Combination Therapy
13%
Apolipoprotein E
13%
Fatty Acid
13%
Hypertriglyceridemia
12%
Lipoprotein Lipase
11%
Lipoprotein A
11%
High Density Lipoprotein
10%
Simvastatin
9%
Familial Hypercholesterolemia
9%
Low Density Lipoprotein Receptor
9%
Ischemic Heart Disease
9%
Pancreatic Lipase
9%
Atherosclerosis
8%
Cholesterol Ester Transfer Protein
8%
Apolipoprotein
8%
Nicotinic Acid
7%
Anacetrapib
7%
Hypercholesterolemia
7%
Pathophysiology
7%
Mevinolin
7%
Omega-3 Fatty Acid
7%
Receptor
6%
Normal Human
6%
Ezetimibe
6%
Clinical Trial
6%
Macaca fascicularis
6%
Rosiglitazone
5%
HIV
5%
Medicine and Dentistry
Cardiovascular Disease
30%
Triacylglycerol
29%
Lipoprotein
23%
Low Density Lipoprotein Cholesterol
21%
Dyslipidemia
21%
Insulin Resistance
18%
High Density Lipoprotein Cholesterol
16%
Diabetes Mellitus
14%
Diabetes
14%
Low-Density Lipoprotein
13%
Cardiovascular Risk
12%
Maturity Onset Diabetes of the Young
12%
Apolipoprotein B
11%
Statin
11%
Ischemic Heart Disease
10%
Cardiovascular System
10%
Saturated Fatty Acid
9%
Very Low Density Lipoprotein
9%
Hyperlipidemia
8%
Diseases
8%
Secretion (Process)
7%
Monounsaturated Fatty Acid
7%
Patient with Type 2 Diabetes
6%
Metabolic Syndrome
6%
Risk Reduction
6%
Hypertriglyceridemia
6%
Placebo
6%
Drug Therapy
6%
Atherosclerosis
5%
High Fat Food
5%
Patient with Diabetes
5%
Familial Hypercholesterolemia
5%
Niacin
5%
Cholesterol Intake
5%
Oxidoreductase
5%
Pathophysiology
5%
